Company news
Arovella Therapeutics Limited news in 2020
Arovella Therapeutics Limited's news releases, calls and decks from 2020, newest first.
Company Update - Letter to Shareholders
December 21, 2020
Prospectus - Placement
December 15, 2020
Ordesa Feasibility Study Update
December 15, 2020
Placement Offer to raise $2.76m
December 15, 2020
AGM FY20 Chairmans address and virtual meeting guide
November 25, 2020
AGM FY20 Presentation
November 25, 2020
R & D Tax Incentive refund received
November 23, 2020
Investor Presentation November 2020
November 16, 2020
Anagrelide Cancer Patent For Australia
September 8, 2020
Appendix 4C - quarterly
July 31, 2020
TGA Approval Granted For ZolpiMist
July 28, 2020
Prospectus For Entitlement Offer
July 2, 2020
Entitlement Offer To Raise Approximately $3.56 Million
July 2, 2020
Market Update
June 24, 2020
Suspension from Official Quotation
June 4, 2020
Anagrelide Cancer Patent For Japan
May 20, 2020
SUDA Signs Additional Licence With Mitsubishi Tanabe
March 22, 2020
Half Yearly Report and Accounts
February 26, 2020
Decks in 2020
- Shareholder Meeting (November 2020)
Shareholder meeting · 14 slides · Nov 26, 2020
- Investor Presentation (November 2020)
Investor deck · 15 slides · Nov 17, 2020